Insider holders · CIK 0001711754
Inmune Bio, Inc. · INMB
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Xencor Inc10% Owner | 1,585,000 | — | 1,585,000 | Feb 8, 2019 · 7:31 pm EST | Form 3 |
| Mark William LowdellChief Scientific Officer | 1,518,017 | — | 1,518,017 | Jul 7, 2026 · 7:01 am EDT | Form 4 |
| Raymond Joseph TesiPresident & CEO | 1,515,833 | — | 1,515,833 | Feb 8, 2019 · 4:42 pm EST | Form 3 |
| David J MossChief Executive Officer | 1,294,883 | — | 1,294,883 | Jul 7, 2026 · 7:00 am EDT | Form 4 |
| Timothy j SchroederDirector | — | 166,667 | 166,667 | Feb 8, 2019 · 6:10 pm EST | Form 3 |
| Scott JudaDirector | 86,404 | 12,500 | 98,904 | Jul 7, 2026 · 7:01 am EDT | Form 4 |
| David Edmund SzymkowskiDirector | 1,000 | — | 1,000 | Feb 8, 2019 · 7:33 pm EST | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.